Case TS-5428908216 Oct 2026MixedCompound claim

General

“Researchers studying the compound IU1 have found that enhancing the cell's protein-quality-control systems (proteasomes and autophagy) may help cells clear damaged proteins more efficiently, potentially reducing age-related decline and possibly helping humans live up to 250 years." (Post slide text: "Scientists May Have Found a Drug That…”

This post lists 4 claims. We checked item 1.

Plain restatementA compound called IU1 improves cellular protein quality control (proteasome and autophagy activity), and research on it indicates a possible human lifespan of up to 250 years.

FalseConfidence High
What this verdict means →

There is a real study behind this post, but the "250 years" headline is invented. In 2024, researchers at Chung-Ang University in South Korea published a peer-reviewed paper showing that a compound called IU1 boosted two cellular cleanup systems, the proteasome and autophagy, cleared damaged protein buildup, and extended lifespan in fruit flies. Some of the work was also done in human cells in a dish. No humans or mammals were tested, IU1 is sold only as a laboratory research chemical, and no researcher claimed it could extend human life to 250 years. Reporting that examined the viral wave found the 250-year figure originated on social media, not from the scientists. The post also misses that the benefit vanished in the study when proteasome function was blocked, links a source article about a completely different protein, and ends by promoting a skincare product. The three other claims in the post about ISRIB, an Alzheimer's vaccine, and a DHM serum were not independently checked here and should not be assumed accurate.

The drift / as claimed vs as evidenced

[drifted from the evidence:] Researchers studying the compound IU1 [drifted from the evidence:] have found that enhancing the cell's protein-quality-control systems (proteasomes and autophagy) [drifted from the evidence:] may help cells clear damaged proteins more efficiently, potentially reducing age-related decline and [drifted from the evidence:] possibly helping humans live up to 250 years." (Post slide text: "Scientists May Have Found a [drifted from the evidence:] Drug That Could Help Humans Live Up to 250 Years.")


[added by the neutral restatement:] A compound [added by the neutral restatement:] called IU1 [added by the neutral restatement:] improves cellular protein quality control (proteasome and autophagy [added by the neutral restatement:] activity), and [added by the neutral restatement:] research on it indicates a [added by the neutral restatement:] possible human lifespan of up to 250 years.

Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.

The trace / claim to source

Where it appeared
✕ Fabrication
The claim rests on something that simply does not exist.
◇ Species extrapolation
Findings from animal or lab studies presented as if demonstrated in humans.
∞ Temporal overreach
Short-term or preliminary findings presented as settled, lasting truth.
⌿ Omitted qualifier
A load-bearing condition from the source quietly disappears from the claim.
misattribution
Tertiary source
Chemical supplier listing for IU1 (research-use-only designation)
Tertiary sourceunattributed/agenda-driven
Low-quality aggregators repeating the 250-year figure (geeksaroundglobe.com; X posts)
Secondary sourcerepublished university release
SciTechDaily, "A Breakthrough in Anti-Aging: Korean Scientists Discover Lifespan-Extending Drug" (Sept 2024)
Secondary sourcetrade press tracing the viral number
BeInCrypto / Bitget, "Two Anti-Aging Studies Fuel 250-Year Claims and Crypto's Longevity Bet"
Secondary sourcecited by the post but about a different study
SciTechDaily, "Scientists Discover Key Protein That May Reverse Aging at the Cellular Level" (AP2A1, Osaka University)
Primary sourcepeer-reviewed journal
Hyun et al., "Pharmacological inhibition of USP14 delays proteostasis-associated aging in a proteasome-dependent but foxo-independent manner," Autophagy (2024)
Primary sourceuniversity communications
Chung-Ang University press release via EurekAlert, "Chung-Ang University researchers identify a potential anti-aging drug"
Primary sourcepeer-reviewed, original discovery of IU1
Lee et al., "Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of Usp14," Nature (2010)
● Primary source found
What is true
  • IU1 is a real compound and a selective USP14 inhibitor that enhances proteasome activity.
  • A real peer-reviewed 2024 paper in Autophagy reports that IU1 improved proteasome and autophagy function and reduced damaged-protein aggregates in aging fruit flies and in cultured human cells.
  • IU1 extended lifespan and improved climbing ability in flies.
  • The post's phrasing that this "may help cells clear damaged proteins more efficiently" matches what the authors report.
  • The caption correctly uses hedged language ("may," "potentially") for the mechanism portion.
What is misleading
  • Fabricated figure: the "250 years" number appears in no study, press release, or researcher statement. Trade reporting traced it to social media, not to the scientists. This is fabrication of a headline statistic, not simplification.
  • Species extrapolation: results come from fruit flies and cultured cells. The headline presents them as a drug that "could help humans live up to 250 years." No mammal data, let alone human data, was found.
  • Temporal and translational overreach: a research-only reagent with no human trials is framed as a near-term human longevity drug.
  • Omitted qualifier: the benefit depended on intact proteasome function and was absent in Usp14 mutants. None of this conditionality survives into the post.
  • Misattribution in the surrounding ecosystem: widely reposted as Japanese/Osaka research when it is Korean (Chung-Ang University). The post's first cited source link is to a different study about a different protein (AP2A1), which does not support the IU1 claim at all.
  • Marketing context: the final slide directs readers to a skincare affiliate link, meaning the longevity framing serves a commercial funnel.
What is uncertain
  • The exact magnitude and statistical details of the fly lifespan extension were not retrieved in full text, so I am not reporting a percentage.
  • Whether any preclinical mammalian IU1 aging study exists was not confirmed; my searches found none, but absence of search results is not proof of absence.
  • Three secondary claims in the same post were not independently investigated because the search budget was exhausted on the primary claim: the ISRIB "memory up to 70% younger in 48 hours" figure, the characterization of AV-1959R as "the world's first Alzheimer's vaccine," and the DHM serum study described as reducing epidermal methylation age by about 2.1 years in 60 adults. The ISRIB and DHM percentage figures in particular should be treated as unverified. Note that the post itself concedes the DHM study was short, had no vehicle control, and tested a multi-ingredient formulation.
Evidence summary

A real, peer-reviewed study underlies the mechanism part of this claim. The authors state that activation of the UPS via pharmacological inhibition of USP14 using IU1 improves proteostasis and autophagy decline caused by aging or proteostatic stress in Drosophila and human cells. Increased polyubiquitinated protein aggregates in Drosophila flight muscles and a decline in UPS and autophagy activity were prominent in aged flies or flies fed amino acid analogs, and these symptoms were significantly improved by IU1; the heightened autophagy activity was reduced when proteasomal activity was inhibited. Treatment with IU1 alleviated aggregation of polyubiquitinated proteins in aging fly flight muscles and extended fly lifespan with enhanced locomotive activity, and the drug's effect disappeared when proteasomal activity was inhibited. The experimental systems were insects and cultured cells. A research team from Korea tested IU1 on proteasomes and autophagy using fruit flies as an animal model and found it can prevent age-related decline in proteostasis. The human-cell work was in vitro: IMR90-hTERT cells were incubated with IU1 and analyzed for autophagic flux by LC3B immunoblotting. Nothing in the study or the university announcement mentions 250 years, human lifespan, or any human application. Trade reporting that examined the viral wave concluded the findings fed a viral online claim that humans could soon live to 250, that the number came from social media rather than the scientists behind the work, and that no researcher made that claim, with flies rather than people being the organisms that lived longer.

Complete reasoning
The underlying science is real and the mechanism sentence is a fair summary of a genuine 2024 Autophagy paper from Chung-Ang University, but the claim's defining element, that this research points to humans living up to 250 years, is a number that exists in no primary source and was attached to the work after the fact on social media. The research tested fruit flies and cultured human cells, IU1 is a research-only reagent with no human trials, and the paper itself shows the effect disappears without intact proteasome function. Per the standard that a fabricated headline figure is not rescued by a loosely related real study, the claim as presented is false even though its first clause is accurate. Confidence is high because the primary paper, the university press release, and the original 2010 characterization of IU1 were all retrieved and none contain anything resembling the 250-year assertion.
Use this case

The reply is formatted for pasting into the thread where the claim is circulating.

Ask this case

Answers come only from the case file above; nothing is added.

Is it true that scientists found a drug that could let humans live up to 250 years?

No. This claim is rated false. The 250 years figure does not appear in any study, press release, or statement from the researchers; it originated on social media, not from scientists.

What did the actual study on IU1 find?

A 2024 peer-reviewed study from Chung-Ang University in South Korea found that IU1, a compound that boosts proteasome and autophagy activity, reduced damaged-protein buildup and extended lifespan and improved movement in fruit flies. Some related work was done in human cells in a lab dish, but no mammals or humans were tested.

Has IU1 been tested on humans or other mammals?

No. The investigation found no evidence of any mammal or human trials. IU1 is currently sold only as a laboratory research chemical.

Why does this claim count as false if there is a real study behind it?

The underlying science is real, but the post stretches it far beyond what was shown: it turns fly and cell-culture results into a claim about human lifespan, adds a fabricated 250-year figure, and drops the finding that the benefit disappeared when proteasome function was blocked.

What about the other claims in the same post, like ISRIB and the DHM skincare serum?

The case file did not independently verify those claims. The ISRIB memory figure and the DHM serum's anti-aging percentage should be treated as unverified, and the post itself notes the DHM study was short and lacked a control group.

Similar cases on record

False: A compound called IU1 improves cellular protein quality control (proteasome and autophagy … | TrueSeeker